Infections in a surgical intensive care unit of a university hospital in Greece

International Journal of Infectious Diseases

Volumn 13, Issue 2, 2009, Pages 145-153

  Markogiannakis, Haridimos ^a   Pachylaki, Nikoleta ^a   Samara, Eleni ^a   Kalderi, Melpomeni ^a   Minettou, Maria ^a   Toutouza, Marina ^a   Toutouzas, Konstantinos G ^a   Theodorou, Dimitrios ^a   Katsaragakis, Stilianos ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Enterococcus faecium; Infections; Microorganisms; Morbidity; Mortality; Multi drug resistance; Surgical intensive care unit; Ventilator associated pneumonia

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METICILLIN; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULTAMICILLIN; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ACUTE PANCREATITIS; ADULT; AGED; ANTIBIOTIC RESISTANCE; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CENTRAL VENOUS CATHETER; DEATH; DRUG USE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; GREECE; HOSPITAL INFECTION; HUMAN; INDWELLING CATHETER; INFECTION RISK; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERITONITIS; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTOR; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

AGED; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; DRUG RESISTANCE, MULTIPLE; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE COCCI; GREECE; HOSPITALS, UNIVERSITY; HUMANS; INFECTION; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; SEPSIS;

EID: 61349180132     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.05.1227     Document Type: Article

References (30)

1. Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.H., et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274 (1995) 639-644
2. Sligl W., Taylor G., and Brindley P.G. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int J Infect Dis 10 (2006) 320-325
3. Streit J.M., Jones R.N., Sader H.S., and Fritsche T.R. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents 24 (2004) 111-118
4. Erbay H., Yalcin A.N., Serin S., Turgut H., Tomatir E., Cetin B., et al. Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey. Intensive Care Med 29 (2003) 1482-1488
5. Safdar N., and Maki D.G. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, Gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 136 (2002) 834-844
6. Fridkin S.K., Steward C.D., Edwards J.R., Pryor E.R., McGowan Jr. J.E., Archibald L.K., et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 29 (1999) 245-252
7. Yildirim S., Nursal T.Z., Tarim A., Torer N., Noyan T., Demiroglu Y.Z., et al. Bacteriological profile and antibiotic resistance: comparison of findings in a burn intensive care unit, other intensive care units, and the hospital services unit of a single center. J Burn Care Rehabil 26 (2005) 488-492
8. Rhomberg P.R., Fritsche T.R., Sader H.S., and Jones R.N. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA). Diagn Microbiol Infect Dis 56 (2006) 57-62
9. Hanberger H., Garcia-Rodriguez J.A., Gobernado M., Goossens H., Nilsson L.E., and Struelens M.J. Antibiotic susceptibility among aerobic Gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA 281 (1999) 67-71
10. Edgeworth J.D., Treacher D.F., and Eykyn S.J. A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med 27 (1999) 1421-1428
11. Richards M.J., Edwards J.R., Culver D.H., and Gaynes R.P. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21 (2000) 510-515
12. Meric M., Willke A., Caglayan C., and Toker K. Intensive care unit-acquired infections: incidence, risk factors and associated mortality in a Turkish university hospital. Jpn J Infect Dis 58 (2005) 297-302
13. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 16 (1988) 128-140
14. Horan T.C., Gaynes R.P., Martone W.J., Jarvis W.R., and Emori T.G. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 20 (1992) 271-274
15. Calandra T., Cohen J., and International Sepsis Forum Definition of Infection in the ICU Consensus Conference. The International Sepsis Forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33 (2005) 1538-1548
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 11th Informational Supplement. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards; 2002, p. M100-S12.
17. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985) 818-829
18. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonca A., Bruining H., et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22 (1996) 707-710
19. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-74.
20. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31 (2003) 1250-1256
21. Rello J. Acinetobacter baumannii infections in the ICU: customization is the key. Chest 115 (1999) 1226-1229
22. Villari P., Iacuzio L., Vozzella E.A., and Bosco U. Unusual genetic heterogeneity of Acinetobacter baumannii isolates in a university hospital in Italy. Am J Infect Control 27 (1999) 247-253
23. Richards M.J., Edwards J.R., Culver D.H., and Gaynes R.P. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 27 (1999) 887-892
24. Laupland K.B., Bagshaw S.M., Gregson D.B., Kirkpatrick A.W., Ross T., and Church D.L. Intensive care unit-acquired urinary tract infections in a regional critical care system. Crit Care 9 (2005) R60-R65
25. Michalopoulos A.S., Tsiodras S., Rellos K., Mentzelopoulos S., and Falagas M.E. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 11 (2005) 115-121
26. Reina R., Estenssoro E., Saenz G., Canales H.S., Gonzalvo R., Vidal G., et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med 31 (2005) 1058-1065
27. Palabiyikoǧlu I., Oral M., and Tulunay M. Candida colonization in mechanically ventilated patients. J Hosp Infect 47 (2001) 239-242
28. el-Ebiary M., Torres A., Fàbregas N., de la Bellacasa J.P., González J., Ramirez J., et al. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study. Am J Respir Crit Care Med 156 2 Pt 1 (1997) 583-590
29. Cookson B.D., Macrae M.B., Barrett S.P., Brown D.F., Chadwick C., French G.L., et al., Combined Working Party of the Hospital Infection Society and Infection Control Nurses Association. Guidelines for the control of glycopeptide-resistant enterococci in hospitals. J Hosp Infect 62 (2006) 6-21
30. Hiramatsu K., Aritaka N., Hanaki H., Kawasaki S., Hosoda Y., Hori S., et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350 (1997) 1670-1673